Literature DB >> 22210650

Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.

Zhongheng Zhang1, Hongying Ni, Baolong Lu.   

Abstract

One of the greatest problems in performing continuous renal replacement therapy (CRRT) is premature coagulation of the circuit. The aim of the current study was to monitor the circuit function prospectively and analyze patient-related variables that may affect circuit life. Critically ill patients admitted to the intensive care unit of a tertiary hospital between August 2010 and August 2011 receiving continuous veno-venous hemofiltration (CVVH) with systemic heparin anticoagulation were prospectively studied. Variables including body temperature, blood pH value, ionized calcium level, activated partial thromboplastin time (aPTT), prothrombin time (PT), platelet count, and heparin dose were collected and analyzed for their association with circuit life span. Fifty-four patients treated by CVVH were included, with 255 filters. The filter life was 29.7 ± 13.4 hours (mean ± standard deviation [SD]). Circuits with longer survival time appeared to have lower body temperature (37.80 ± 1.14 vs. 36.36 ± 1.09; p< 0.05), lower levels of serum ionized calcium (0.80 vs. 1.29; p< 0.05), and to be more acidic (7.233 vs. 7.377; p< 0.05). Cox regression showed that pH value and ionized calcium levels were significantly associated with circuit life. Other variables of hematocrit, albumin levels, platelet count, aPTT, PT, or dose of heparin were not significantly associated with circuit life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22210650     DOI: 10.1097/MAT.0b013e31823fdf20

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  8 in total

1.  Semi-parametric regression model for survival data: graphical visualization with R.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2016-12

2.  The benefit of specialized team approaches in patients with acute kidney injury undergoing continuous renal replacement therapy: propensity score matched analysis.

Authors:  Hyung Jung Oh; Mi Jung Lee; Chan Ho Kim; Dae Young Kim; Hye Sun Lee; Jung Tak Park; Sungwon Na; Seung Hyeok Han; Shin-Wook Kang; Shin Ok Koh; Tae-Hyun Yoo
Journal:  Crit Care       Date:  2014-08-13       Impact factor: 9.097

3.  Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.

Authors:  Louise Schilder; S Azam Nurmohamed; Frank H Bosch; Ilse M Purmer; Sylvia S den Boer; Cynthia G Kleppe; Marc G Vervloet; Albertus Beishuizen; Armand R J Girbes; Pieter M Ter Wee; A B Johan Groeneveld
Journal:  Crit Care       Date:  2014-08-16       Impact factor: 9.097

4.  The effect of specialized continuous renal replacement therapy team in acute kidney injury patients treatment.

Authors:  Youn Kyung Kee; Eun Jin Kim; Kyoung Sook Park; Seung Gyu Han; In Mee Han; Chang Yun Yoon; Eunyoung Lee; Young Su Joo; Dae Young Kim; Mi Jung Lee; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Beom Seok Kim; Shin-Wook Kang; Kyu Hun Choi; Hyung Jung Oh
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

Review 5.  Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis.

Authors:  Matthew Brain; Elizabeth Winson; Owen Roodenburg; John McNeil
Journal:  BMC Nephrol       Date:  2017-02-20       Impact factor: 2.388

6.  Anemia, Blood Transfusion, and Filter Life Span in Critically Ill Patients Requiring Continuous Renal Replacement Therapy for Acute Kidney Injury: A Case-Control Study.

Authors:  Hasan M Al-Dorzi; Nora Ali Alhumaid; Nouf Hamad Alwelyee; Nouf Mubark Albakheet; Ramah Ibrahim Nazer; Sadal Khalid Aldakhil; Shahad Abdulaziz AlSaif; Nazish Masud
Journal:  Crit Care Res Pract       Date:  2019-01-28

7.  Development and External Validation of a Model for Predicting Sufficient Filter Lifespan in Anticoagulation-Free Continuous Renal Replacement Therapy Patients.

Authors:  Wei Zhang; Ming Bai; Ling Zhang; Yan Yu; Yangping Li; Lijuan Zhao; Yuan Yue; Yajuan Li; Min Zhang; Ping Fu; Shiren Sun; Xiangmei Chen
Journal:  Blood Purif       Date:  2021-10-21       Impact factor: 3.348

8.  Filter clotting with continuous renal replacement therapy in COVID-19.

Authors:  Paul Endres; Rachel Rosovsky; Sophia Zhao; Scott Krinsky; Shananssa Percy; Omer Kamal; Russel J Roberts; Natasha Lopez; Meghan E Sise; David J R Steele; Andrew L Lundquist; Eugene P Rhee; Kathryn A Hibbert; C Corey Hardin; Finnian R Mc Causland; Peter G Czarnecki; Walter Mutter; Nina Tolkoff-Rubin; Andrew S Allegretti
Journal:  J Thromb Thrombolysis       Date:  2020-10-07       Impact factor: 2.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.